Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2010
12/30/2010US20100331355 Substituted Quinolines for the Treatment of Cancer
12/30/2010US20100331350 Inhibitors of bruton's tyrosine kinase
12/30/2010US20100331334 Inhibitors of mek
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331328 Bicyclylaryl-aryl-amine compounds and their use
12/30/2010US20100331327 7-substituted indirubin-3'oximes and their applications
12/30/2010US20100331326 Inhibitors of CYP 17
12/30/2010US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
12/30/2010US20100331316 5-phenyl-lh-benz0 [e] [1,4] diazepine compounds substituted with an hydroxamic acid group as histone deacetylase inhibitors
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331314 Pyrazolopyrimidines and related heterocycles as kinase inhibitors
12/30/2010US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors
12/30/2010US20100331307 Therapeutic compounds and compositions
12/30/2010US20100331306 Heterocyclic compounds and their uses
12/30/2010US20100331305 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331301 Azetidine compound and pharmaceutical use thereof
12/30/2010US20100331296 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331293 Heterocyclic compounds and their uses
12/30/2010US20100331290 Taxane delivery system
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100331273 Self-assembling complex for targeting chemical agents to cells
12/30/2010US20100331269 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
12/30/2010US20100331263 Methods and compositions for inhibiting angiogenesis
12/30/2010US20100331249 Pharmaceutical composition for inhibiting peritoneal dissemination
12/30/2010US20100331243 Organic compounds and their uses
12/30/2010US20100331239 Cd14 and peptides thereof for protection of cells against cell death
12/30/2010US20100331234 Aminoalcohol lipidoids and uses thereof
12/30/2010US20100331233 Crystal of xpa and ercc1 complex and uses thereof
12/30/2010US20100331232 Starch-based hydrogel for biomedical applications
12/30/2010US20100330613 Methods for determining efficacy of chemotherapeutic agents
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330213 Estrogenic Extracts of Morus Alba and Uses Thereof
12/30/2010US20100330201 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds
12/30/2010US20100330200 Combination of a retinoid and a platinum anticancer agent
12/30/2010US20100330197 Oral or enteral composition useful for recovery of physical functions
12/30/2010US20100330194 Silicon Substituted Phosphates
12/30/2010US20100330174 Betaine compositions
12/30/2010US20100330166 Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
12/30/2010US20100330159 System for transporting active substances in a biological system
12/30/2010US20100330157 Biomaterial for the controlled delivery of ingredients
12/30/2010US20100330154 amphoteric liposomes comprising neutral lipids
12/30/2010US20100330152 Methods and compositons for antisense vegf oligonucleotides
12/30/2010US20100330148 Mehods and compositions for inhibiting impdh-1 isoform 1
12/30/2010US20100330145 Biobeneficial coating compositions and methods of making and using thereof
12/30/2010US20100330138 Biostable, multipurpose, microbicidal intravaginal devices
12/30/2010US20100330130 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330107 Antibody drug conjugates (adc) that bind to 24p4c12 proteins
12/30/2010US20100330106 Method of Treating Cancer with DLL4 Antagonist and Chemotherapeutic Agent
12/30/2010US20100330105 Anticancer Combination Therapies
12/30/2010US20100330103 Antibodies Directed to Alpha V Beta 6 And Uses Thereof
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330093 Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)
12/30/2010US20100330090 Antagonist antibodies of protease activated receptor-1 (par1)
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330087 Methods for treating cancer using combination therapy
12/30/2010US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330081 Cripto binding molecules
12/30/2010US20100330079 Biomarkder combinations for colorectal cancer
12/30/2010US20100330078 Alpha 5 - beta 1 antibodies and their uses
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330073 Methods of treatment using antibodies to neutrokine-alpha
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330062 Klotho protein and related compounds for the treatment and diagnosis of cancer
12/30/2010US20100330057 Method of evaluating human dentritic cells and human cell immunotherapeutic agent
12/30/2010US20100330056 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
12/30/2010US20100330051 Polypeptide having an improved cytosine deaminase activity
12/30/2010US20100330046 Human skin substitutes expressing il-12
12/30/2010US20100330043 Gpr125 as a marker for stem and progenitor cells and methods use thereof
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100330031 Polypeptide having an improved cytosine deaminase activity
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100330029 Cancer Treatments with Radiation and Immunocytokines
12/30/2010US20100330026 Organic polymeric photon up-conversion nanoparticles for biological applications
12/30/2010US20100330023 Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
12/30/2010US20100329991 Medicinal preparation particularly for the treatment of slipped discs hernias
12/30/2010US20100329984 Respiratory dispersion for metered dose inhalers
12/30/2010US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery
12/30/2010US20100329981 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/30/2010US20100329976 Nanoparticulate compositions of angiogenesis inhibitors
12/29/2010WO2010151710A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
12/29/2010WO2010151541A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
12/29/2010WO2010151517A2 Antigen-specific long-term memory t-cells
12/29/2010WO2010151076A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
12/29/2010WO2010151074A2 Photosensitizer containing conjugates of quantum dot-chlorine derivatives and composition for treating and diagnosing cancer containing same for photodynamic therapy
12/29/2010WO2010151073A2 Conjugates of anticancer chemotherapeutic agent-chlorine derivatives, photosensitizer containing same and composition for treating cancer containing same
12/29/2010WO2010151005A2 Injectable composition containing hydroxychloroquine for local administration for treating cancer
12/29/2010WO2010150927A1 Pharmaceutical composition for prevention and treatment of cancer diseases comprising benzamide derivatives
12/29/2010WO2010150255A1 Conjugates of cytotoxic drugs
12/29/2010WO2010150211A2 Use of derivatives of indoles for the treatment of cancer
12/29/2010WO2010150100A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
1 ... 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 ... 2211